Results 141 to 150 of about 10,243,879 (347)
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz +15 more
wiley +1 more source
Comparison of manual data coding errors in two hospitals. [PDF]
Patrick A. V. Hall, Nancy Lemoine
openalex +1 more source
The noncoding region of the genome plays a key role in regulating gene expression, and mutations within these regions are capable of altering it. Researchers have identified multiple functional noncoding mutations associated with increased cancer risk in the genome of breast cancer patients.
Arnau Cuy Saqués +3 more
wiley +1 more source
L’umanità al varco. L’intelligenza artificiale può essere lo “scrigno” delle verità sull’essere umano [PDF]
When observing contemporary society, one cannot fail to notice how pressing man’s desire to ‘domesticate’ his own existence is wanting to make it completely similar to a linear and controlled process.
Nausica Lucia Guglielmo
doaj
Matrix Code Based Error Correction for LUT Based Cyclic Redundancy Check
Neepa P. Mathew, Anith Mohan
openalex +1 more source
Positioning Error of Feed Axis Decouple-separating Modeling and Compensating Research for CNC Machine Tools [PDF]
Xiaopeng Yao
openalex +1 more source
Combining PTEN protein assessment and transcriptomic profiling of prostate tumors, we uncovered a network enriched in senescence and extracellular matrix (ECM) programs associated with PTEN loss and conserved in a mouse model. We show that PTEN‐deficient cells trigger paracrine remodeling of the surrounding stroma and this information could help ...
Ivana Rondon‐Lorefice +16 more
wiley +1 more source
Improving the accuracy of the Newmark method through backward error analysis [PDF]
Donát M. Takács, Tamás Fülöp
openalex +1 more source
Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute +17 more
wiley +1 more source
Cell surface interactome analysis identifies TSPAN4 as a negative regulator of PD‐L1 in melanoma
Using cell surface proximity biotinylation, we identified tetraspanin TSPAN4 within the PD‐L1 interactome of melanoma cells. TSPAN4 negatively regulates PD‐L1 expression and lateral mobility by limiting its interaction with CMTM6 and promoting PD‐L1 degradation.
Guus A. Franken +7 more
wiley +1 more source

